AU7295696A - Pharmaceutical composition for treating osteoporosis - Google Patents

Pharmaceutical composition for treating osteoporosis

Info

Publication number
AU7295696A
AU7295696A AU72956/96A AU7295696A AU7295696A AU 7295696 A AU7295696 A AU 7295696A AU 72956/96 A AU72956/96 A AU 72956/96A AU 7295696 A AU7295696 A AU 7295696A AU 7295696 A AU7295696 A AU 7295696A
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
treating osteoporosis
osteoporosis
treating
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72956/96A
Inventor
John Joseph Nestor
Milan Radoje Uskokovic
Brian Henry Vickery
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU7295696A publication Critical patent/AU7295696A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
AU72956/96A 1995-10-27 1996-10-18 Pharmaceutical composition for treating osteoporosis Abandoned AU7295696A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US596695P 1995-10-27 1995-10-27
US005966 1995-10-27
PCT/EP1996/004532 WO1997016193A1 (en) 1995-10-27 1996-10-18 Pharmaceutical composition for treating osteoporosis

Publications (1)

Publication Number Publication Date
AU7295696A true AU7295696A (en) 1997-05-22

Family

ID=21718613

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72956/96A Abandoned AU7295696A (en) 1995-10-27 1996-10-18 Pharmaceutical composition for treating osteoporosis

Country Status (4)

Country Link
AR (1) AR003089A1 (en)
AU (1) AU7295696A (en)
WO (1) WO1997016193A1 (en)
ZA (1) ZA969021B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU733970B2 (en) * 1996-05-23 2001-05-31 F. Hoffmann-La Roche Ag Fluorinated vitamin D3 analogs

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939408A (en) 1996-05-23 1999-08-17 Hoffman-La Roche Inc. Vitamin D3 analogs
ES2192136B1 (en) * 2002-01-04 2005-03-16 Italfarmaco, S.A. PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF OSTEOPOROSIS.
CN114588176B (en) * 2022-02-15 2024-01-23 许静宜 Method for researching ophiopogonin D to promote osteoporosis H-type blood vessel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
DE69304279T2 (en) * 1992-05-20 1997-02-20 Hoffmann La Roche Fluorinated Analogs of Vitamins D3

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU733970B2 (en) * 1996-05-23 2001-05-31 F. Hoffmann-La Roche Ag Fluorinated vitamin D3 analogs

Also Published As

Publication number Publication date
AR003089A1 (en) 1998-07-08
WO1997016193A1 (en) 1997-05-09
ZA969021B (en) 1998-04-28

Similar Documents

Publication Publication Date Title
HUP9802086A3 (en) Pharmaceutical composition for piperidinoalkanol compounds
AU1128297A (en) Composition for treating pain
AU6216296A (en) Pharmaceutical compositions
HU9601698D0 (en) Pharmaceutical composition
AU1139095A (en) Combination treatment for osteoporosis
AU6904896A (en) Pharmaceutical compounds
IL118590A (en) Pharmaceutical composition for minimizing bone loss
AU5155096A (en) Pharmaceutical composition
ZA964373B (en) A pharmaceutical composition for treating lukemia
GB9519667D0 (en) Pharmaceutical composition
ZA963590B (en) Pharmaceutical composition
AU5274096A (en) Pharmaceutical compositions
ZA961051B (en) Pharmaceutical composition
ZA9610426B (en) Pharmaceutical composition
ZA964193B (en) Pharmaceutical composition
AU7295696A (en) Pharmaceutical composition for treating osteoporosis
IL118573A (en) Pharmaceutical compositions for minimizing bone loss
AU6814496A (en) Pharmaceutical composition
ZA963591B (en) Pharmaceutical composition
ZA95736B (en) Pharmaceutical composition
AU741226C (en) Pharmaceutical composition
AU723097C (en) Pharmaceutical composition
ZA961389B (en) Pharmaceutical composition for piperidinoalkanol compounds
SI0812195T1 (en) Pharmaceutical composition for piperidinoalkanol compounds
ZA968383B (en) Composition for treatment of osteoporosis.